BlackRock, Inc. 13D and 13G filings for Brainstorm Cell Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Brainstorm Cell Therapeutics Inc. BCLI | BlackRock Inc. BLK | 31,623 1.300% | -96,400 (-75.30%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI | BlackRock Inc. BLK | 128,023 6.100% | 128,023 (New Position) | Filing |